Sponsor

Janssen Korea, Ltd., Korea

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Janssen Korea, Ltd., Korea appears in 25 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials25
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

25 shown
A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of IntelenceNCT01741844 · lead sponsor · 2012-09-01
COMPLETED
A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of PrezistaNCT01741831 · lead sponsor · 2012-07-01
COMPLETED
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugNCT01592201 · lead sponsor · 2012-07-01
TERMINATED
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone PalmitateNCT01682161 · lead sponsor · 2012-01-01
COMPLETED
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in KoreaNCT01294722 · lead sponsor · 2011-12-01
COMPLETED
A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic PatientsNCT01819818 · lead sponsor · 2011-05-23
COMPLETED
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic ParticipantsNCT00761605 · lead sponsor · 2008-04-01
COMPLETED
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic ParticipantsNCT00784238 · lead sponsor · 2008-04-01
COMPLETED
Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic RemissionNCT00761579 · lead sponsor · 2008-04-01
COMPLETED
PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute SchizophreniaNCT00761189 · lead sponsor · 2008-02-01
COMPLETED
An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective DisorderNCT00992407 · lead sponsor · 2007-12-01
COMPLETED
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsNCT00760669 · lead sponsor · 2007-05-01
COMPLETED
A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's DiseaseNCT01734395 · lead sponsor · 2007-03-01
COMPLETED
A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic NeuropathyNCT00634543 · lead sponsor · 2006-12-01
COMPLETED
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's DiseaseNCT01054976 · lead sponsor · 2006-10-01
COMPLETED
Fentanyl Matrix in Lung Cancer PainNCT01060137 · lead sponsor · 2006-05-01
COMPLETED
An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With SchizophreniaNCT00269919 · lead sponsor · 2005-08-01
COMPLETED
A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone MicrospheresNCT00216528 · lead sponsor · 2005-07-01
COMPLETED
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)NCT00294008 · lead sponsor · 2004-12-01
COMPLETED
The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeNCT00216515 · lead sponsor · 2004-03-01
COMPLETED
ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.NCT00246168 · lead sponsor
COMPLETED
Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)NCT01310387 · collaborator · 2011-01-01
COMPLETED
Different Safety Profile of Risperidone and Paliperidone Extended-releaseNCT01284959 · collaborator · 2010-06-01
COMPLETED
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With SchizophreniaNCT00827840 · collaborator · 2008-11-01
COMPLETED
Characteristics of Treatment Responders to GalantamineNCT01029132 · collaborator · 2007-04-01
COMPLETED

Drugs studied in this sponsor's trials

8 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Janssen Korea, Ltd., Korea as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
paliperidone4
galantamine3
risperidone3
gabapentin1
galantamine hydrobromide1
paliperidone palmitate1
placebo1
risperidone Oral Tablet1
paliperidone RxCUI 679314 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials galantamine RxCUI 4637 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 3 trials risperidone RxCUI 35636 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 3 trials gabapentin RxCUI 25480 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial galantamine hydrobromide RxCUI 860693 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paliperidone palmitate RxCUI 858045 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial risperidone Oral Tablet RxCUI 373791 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor21
collaborator4
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.